FDA Adverse Event Injury Summary report: N

DXTEND GLENOSPHERE STD D42MM

MDR report key: 2231601 · Received September 1, 2011

Report

Report Number
1818910-2011-17089
Event Type
Injury
Date Received
September 1, 2011
Date of Event
August 8, 2011
Report Date
August 8, 2011
Manufacturer
DEPUY FRANCE
Product Code
HSD
PMA / PMN Number
K062250
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE ASSOCIATED WITH THIS REPORT WAS NOT RETURNED. A DEPUY (B)(4) SUPPLIER REVIEWED THE DEVICE HISTORY RECORDS AND FOUND THE PRODUCTS CONFORMED TO THE REQUIRED SPECIFICATIONS AND FOUND NO MANUFACTURING DEVIATIONS OR ANOMALIES. A SEARCH OF THE COMPLAINT DATABASE FOUND NO PRIOR REPORTS FOR BOTH OF THE REPORTED PART AND LOT NUMBER COMBINATIONS. PROVIDED INFORMATION STATES THE PATIENT DISLOCATED WHILE SLEEPING IN AN AWKWARD POSITION. THE SURGEON REMOVED A +3 POLY CUP AND INSERTED A +6 CUP TO TENSION THE DELTOID. PROVIDED INFORMATION MARKED ON THE DEVICE EXPERIENCE REPORT IS MARKED THAT THE PRODUCTS ARE NOT SUSPECTED OF FAILING TO MEET SPECIFICATIONS OR CONTRIBUTING TO THE REPORTED EVENT. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INVESTIGATION, THE NEED FOR CORRECTIVE ACTION IS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ANY ADDITIONAL INFORMATION BE RECEIVED TO CHANGE THE OUTCOME OF THE PERFORMED INVESTIGATION, THE COMPLAINT WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Description of Event or Problem · 1

PATIENT WAS REVISED TO ADDRESS DISLOCATION WHILE SLEEPING IN AN AWKWARD POSITION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DXTEND GLENOSPHERE STD D42MM REVERSE SHOULDER GLENOID COMPONENT HSD DEPUY FRANCE 2487148

Patients

Seq Age Sex Outcome Treatment
1 63 YR Required Intervention